Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sang-Kyung Seo
Chemotherapy Adherence Is a Favorable Prognostic Factor for Elderly Patients With Multiple Myeloma Who Are Treated With a Frontline Bortezomib-Containing Regimen
Yeungnam University Journal of Medicine
Related publications
Efficacy and Safety of Reduced-Intensity Induction Therapy With a Bortezomib-Based Regimen in Elderly Patients With Multiple Myeloma
Therapeutic Advances in Hematology
Hematology
1p21 Deletions Are Strongly Associated With 1q21 Gains and Are an Independent Adverse Prognostic Factor for the Outcome of High-Dose Chemotherapy in Patients With Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Bortezomib Overcomes the Negative Prognostic Impact of Renal Impairment in a Newly Diagnosed Elderly Patient With Multiple Myeloma: A Case Report
Oncology Letters
Cancer Research
Oncology
Phase II Study of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy
British Journal of Haematology
Hematology
Chromosome 1 Abnormalities in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Therapies
Haematologica
Hematology
Bortezomib for the Treatment of Multiple Myeloma Patients
Health Technology Assessment
Medicine
Health Policy
Patients With Breast Cancer Who Are Treated With Chemotherapy Risk Long-Term Nerve Damage
Cancer
Cancer Research
Oncology
Managing Neutropenia by Pegfilgrastim in Patients Affected by Relapsed/Refractory Multiple Myeloma Treated With Bendamustine-Bortezomib-Dexamethasone
Supportive Care in Cancer
Oncology
Indirect Treatment Comparison of Cabazitaxel for Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Been Previously Treated With a Docetaxel-Containing Regimen
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
